Meeting
2016 Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
Authors
Alexander V. Kirichenko
Allegheny Health Network, Pittsburgh, PA
Alexander V. Kirichenko , David S. Parda , Angela Sanguino , Olivier Gayou , Moses S. Raj , Dulabh K. Monga , Ngoc Thai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 360)
DOI
10.1200/jco.2016.34.4_suppl.360
Abstract #
360
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with rucosopasem (GC4711) in the treatment of locally advanced or borderline resectable nonmetastatic pancreatic cancer.
First Author: Sarah E. Hoffe
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical results of dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring for liver tumors using a gimbal-mounted linac: A multi-institutional phase II study.
First Author: Yusuke Iizuka
Poster
2018 Gastrointestinal Cancers Symposium
The role of stereotactic body radiation therapy using the CyberKnife system in limited hepatic metastases.
First Author: Eman ElAlfy
Poster
2017 Gastrointestinal Cancers Symposium
Adjuvant stereotactic body radiotherapy (SBRT) for resected primary and metastatic liver cancers.
First Author: Latifa Bazzi